Experiments with breast cancer cell lines showed that inhibition of the chemokine receptor CXCR4 by a neutralizing antibody abrogates their metastasis to the lung, which expresses the corresponding chemokine ligand, CXCL12 (Muller et al., 2001). Here, CXCL12 is linked to breast cancer.